Expect Lower Anticoagulant Doses to Be Tried to Prevent Recurrent Thrombosis

June 2017

More patients will use LOW-dose direct oral anticoagulants (DOACs) long-term to prevent recurrent venous thromboembolism (VTE).

Patients who have a VTE are typically treated with warfarin or a DOAC (Eliquis, etc) for 3 months.

This is usually long enough if an initial VTE was caused by a short-term risk...such as a minor trauma or surgery.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Hypertension Try to Aim for a Systolic BP of 120 or Less in High-Risk Patients
PPIs Know When Short- or Long-Term Use of PPIs Is Appropriate
Women's Health Letrozole Will Be Used More Often for Infertility
Psychiatry Have an "Exit Plan" for Antipsychotics in Dementia Patients
Ear Health Help Choose Appropriate Ear Drops for Kids with Ear Tubes
Fibromyalgia Emphasize Nondrug Measures for Fibromyalgia
Migraine Suggest Therapies to Prevent Menstrual Migraine
Opioids Avoid Tramadol in Children When Possible
Antithrombotics Expect Lower Anticoagulant Doses to Be Tried to Prevent Recurrent Thrombosis
Acute Pain Dispel the Myth That Ketorolac Is a Stronger NSAID